Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

21.70
Delayed Data
As of Jul 20
 -0.01 / -0.05%
Today’s Change
13.01
Today|||52-Week Range
22.17
+15.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues120.8M152.7M192.1M163.8M
 
 
 
 
 
Cost of Goods Sold74.5M108.5M133.3M105.9M
 
 
 
 
 
Depreciation And Amortization7.8M15.0M19.3M16.9M
 
 
 
 
 
 
Operating ExpensesGross Income38.6M29.3M39.5M41.0M
 
 
 
 
 
General Expenses31.4M41.9M37.1M36.8M
 
 
 
 
 
Research And Development3.5M4.6M4.8M3.4M
 
 
 
 
 
Total Operating Expenses113.6M165.4M189.7M159.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income7.2M-12.7M2.5M4.2M
 
 
 
 
 
Extraordinary Charge-7.1M-3.0M-7.9M-2.2M
 
 
 
 
 
Interest Expense On Debt7.1M12.7M13.0M12.8M
 
 
 
 
 
Other Expenses740.0K-549.0K5.9M-793.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.3M-28.9M-12.5M-11.5M
 
 
 
 
 
Income Taxes-15.0M-5.5M-2.9M-850.0K
 
 
 
 
 
Net Income-21.3M-23.4M-15.4M-10.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.9M41.3M42.9M42.4M
 
 
 
 
 
Shares To Calculate EPS Diluted34.9M41.3M42.9M42.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.61-$0.57-$0.37-$0.25
 
 
 
 
 
EPS Diluted-$0.61-$0.57-$0.36-$0.25